The most complete parasite protection in one monthly chew for your dog
Protect your pet against fleas, ticks, mites, heartworm disease, lungworm disease, and intestinal worms with ease by using NexGard SPECTRA® chew.
NexGard SPECTRA® for Dogs
Image
Image
Image
Image
Image
Image
Image
Image
Image
Product details
-
Rapidly kills fleas
-
Treats and controls ticks
-
Treats and controls mange and mites
-
Prevents heartworms and lungworms diseases
-
Treats and controls roundworms, hookworms, and whipworms
-
Swimming, bathing, and shampooing won't reduce its effectiveness
-
Stroke and cuddle your dog straight away
-
Protection from 8 weeks of age and 2kg bodyweight
-
Available in 3 monthly protection packs
-
Tasty monthly chew that dogs love
Two Paragraphs
Easy for you. Tasty for them
NexGard SPECTRA® comes in a tasty beef-flavored chew and is offered in five different sizes to cater to dogs and puppies based on their weight.
Call to Action
Understand more about NexGard® brand
Know what is the appropriate protection against internal and external parasites according to your pet's diagnosis
| NexGard SPECTRA® | Brand A (moxidectin, imidacloprid) | Brand B (fluralaner) | Brand C (sarolaner, moxidectin and pyrantel) | |
|---|---|---|---|---|
Fleas |
applicable | applicable | applicable | applicable |
Ticks |
applicable | applicable | applicable | |
Mites |
applicable | applicable | applicable | applicable |
Heartworms |
applicable | applicable | ||
Roundworms |
applicable | applicable | ||
Hookworms |
applicable | applicable | ||
Whipworms |
applicable | applicable | ||
Flea Tapeworm* |
applicable | applicable |
*NexGard SPECTRA® indirectly protects against Canine Tapeworms by eliminating fleas.
Safety Profile
All medicines, including veterinary medicines, carry benefits and risks. NexGard SPECTRA® contains the active ingredient afoxolaner. Afoxolaner is part of the isoxazoline family of chemicals. Adverse reactions to this family of chemicals are rarely observed but may include vomiting, diarrhoea, lethargy, inappetence (loss of appetite), itching and very rarely, seizures. Most adverse reactions are mild, self-limiting and of short duration. For dogs with a history of epilepsy or other seizure disorders, it is recommended to seek veterinary advice prior to treatment with medicines of this class. Milbemycin oxime, the other active ingredient in NexGard SPECTRA®, is part of the macrocyclic lactone family of chemicals. Adverse reactions to milbemycin oxime are rarely observed at recommended doses.
Rigorous safety studies demonstrate NexGard SPECTRA® excellent safety profile. This is further supported by Boehringer Ingelheim’s rigorous pharmacovigilance program which closely monitors and evaluates any suspected adverse events reported to the company by pet owners or veterinarians in all countries where the product is registered.
For more information please read the product information leaflets. If you have any questions or concerns about NexGard SPECTRA®, we encourage you to contact your Veterinarian or Contact Us.